2024 Q1 Form 10-K Financial Statement
#000149315224012016 Filed on March 29, 2024
Income Statement
Concept | 2024 Q1 | 2023 Q4 | 2023 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $196.7K | $693.3K | $1.283M |
YoY Change | -1.78% | 84.02% | 38.08% |
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $22.89K | $26.12K | $76.12K |
YoY Change | -6.72% | -1.73% | -46.27% |
% of Gross Profit | |||
Operating Expenses | $219.6K | $710.2K | $1.351M |
YoY Change | 1.1% | 78.9% | 35.01% |
Operating Profit | |||
YoY Change | |||
Interest Expense | -$251.9K | -$205.9K | -$815.9K |
YoY Change | -246.68% | -5.63% | -4.58% |
% of Operating Profit | |||
Other Income/Expense, Net | -$58.77K | ||
YoY Change | -93.13% | ||
Pretax Income | -$471.5K | -$159.1K | -$1.410M |
YoY Change | -5.32% | -74.15% | -24.03% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$471.4K | -$184.5K | -$1.410M |
YoY Change | -5.32% | -71.21% | -24.03% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | -$0.01 | -$0.04 | |
Diluted Earnings Per Share | -$0.01 | $0.00 | -$0.04 |
COMMON SHARES | |||
Basic Shares Outstanding | 36.30M shares | 36.30M shares | 37.44M shares |
Diluted Shares Outstanding | 36.30M shares | 37.44M shares |
Balance Sheet
Concept | 2024 Q1 | 2023 Q4 | 2023 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $312.9K | $426.1K | $426.1K |
YoY Change | 1973.43% | 662.43% | 662.43% |
Cash & Equivalents | $312.9K | $426.1K | |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $312.9K | $426.1K | $426.1K |
YoY Change | 1973.58% | 662.5% | 662.43% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $5.233M | $5.233M | $5.233M |
YoY Change | -4.44% | -4.44% | -4.44% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $80.00 | $80.00 | $80.00 |
YoY Change | 0.0% | 0.0% | 0.0% |
Total Long-Term Assets | $5.388M | $5.388M | $5.388M |
YoY Change | -1.61% | -1.61% | -1.61% |
TOTAL ASSETS | |||
Total Short-Term Assets | $312.9K | $426.1K | $426.1K |
Total Long-Term Assets | $5.388M | $5.388M | $5.388M |
Total Assets | $5.701M | $5.814M | $5.814M |
YoY Change | 3.82% | 5.1% | 5.1% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.580M | $1.548M | $1.548M |
YoY Change | -79.63% | -79.25% | 8.68% |
Accrued Expenses | $12.06M | $11.73M | $11.73M |
YoY Change | 10.84% | 11.81% | 11.81% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $3.878M | $3.878M | $3.878M |
YoY Change | 4717.15% | 4717.15% | -0.39% |
Long-Term Debt Due | $1.234M | $1.211M | $1.211M |
YoY Change | -3.81% | -3.37% | -3.37% |
Total Short-Term Liabilities | $19.06M | $18.68M | $18.68M |
YoY Change | 5.94% | 6.56% | 6.56% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $19.06M | $18.68M | $18.68M |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $19.06M | $18.68M | $18.68M |
YoY Change | 5.94% | 6.56% | 6.56% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$47.36M | -$46.86M | |
YoY Change | 3.24% | 3.33% | |
Common Stock | $39.05K | $39.05K | |
YoY Change | 0.0% | 0.0% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $232.9K | $232.9K | |
YoY Change | 7.73% | 7.73% | |
Treasury Stock Shares | |||
Shareholders Equity | -$13.36M | -$12.86M | -$12.86M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $5.701M | $5.814M | $5.814M |
YoY Change | 3.82% | 5.1% | 5.1% |
Cashflow Statement
Concept | 2024 Q1 | 2023 Q4 | 2023 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$471.4K | -$184.5K | -$1.410M |
YoY Change | -5.32% | -71.21% | -24.03% |
Depreciation, Depletion And Amortization | $22.89K | $26.12K | $76.12K |
YoY Change | -6.72% | -1.73% | -46.27% |
Cash From Operating Activities | -$113.2K | -$269.0K | -$439.0K |
YoY Change | 78.91% | 5123.88% | 211.14% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $845.4K | $845.4K | |
YoY Change | |||
Cash From Investing Activities | $845.4K | $845.4K | |
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -176.1K | -$36.11K | |
YoY Change | -131.43% | ||
NET CHANGE | |||
Cash From Operating Activities | -$113.2K | -269.0K | -$439.0K |
Cash From Investing Activities | 845.4K | $845.4K | |
Cash From Financing Activities | -176.1K | -$36.11K | |
Net Change In Cash | -$113.2K | 400.2K | $370.2K |
YoY Change | 177.58% | -7871.65% | -1512.8% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$113.2K | -$269.0K | -$439.0K |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2023 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023 | dei |
Security12g Title
Security12gTitle
|
Common Stock, par value $.001 | |
CY2023 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2023 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2023 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
No | |
CY2023 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2023 | dei |
Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
|
false | |
CY2023 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q2 | dei |
Entity Public Float
EntityPublicFloat
|
7976392 | usd |
CY2024Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
36297576 | shares |
CY2023 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000844887 | |
CY2022Q4 | us-gaap |
Other Receivable After Allowance For Credit Loss Noncurrent
OtherReceivableAfterAllowanceForCreditLossNoncurrent
|
usd | |
CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022 | us-gaap |
Gain Loss On Condemnation
GainLossOnCondemnation
|
usd | |
CY2022 | us-gaap |
Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
|
usd | |
CY2023 | us-gaap |
Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
|
usd | |
CY2022 | us-gaap |
Gain Loss On Condemnation
GainLossOnCondemnation
|
usd | |
CY2022 | us-gaap |
Proceeds From Sale Of Land Held For Use
ProceedsFromSaleOfLandHeldForUse
|
usd | |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | |
CY2022 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
usd | |
CY2022 | us-gaap |
Repayments Of Other Debt
RepaymentsOfOtherDebt
|
usd | |
CY2022 | DHCC |
Repayments Of Other
RepaymentsOfOther
|
usd | |
CY2022 | us-gaap |
Interest Paid Net
InterestPaidNet
|
usd | |
CY2022 | DHCC |
Common Stock To Be Issued In Connection With Notes Payable Others
CommonStockToBeIssuedInConnectionWithNotesPayableOthers
|
usd | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
shares | |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
||
CY2022 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
shares | |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
||
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
shares | |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
||
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
shares | |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
||
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
shares | |
CY2023 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
||
CY2023 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
shares | |
CY2023 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
||
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
shares | |
CY2023 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
||
CY2023 | dei |
Auditor Firm
AuditorFirmId
|
688 | |
CY2023 | dei |
Auditor Name
AuditorName
|
Marcum | |
CY2023 | dei |
Auditor Location
AuditorLocation
|
Marlton, New Jersey | |
CY2023Q4 | us-gaap |
Cash
Cash
|
426124 | usd |
CY2022Q4 | us-gaap |
Cash
Cash
|
55885 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
426124 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
55885 | usd |
CY2023Q4 | us-gaap |
Land
Land
|
5233204 | usd |
CY2022Q4 | us-gaap |
Land
Land
|
5476097 | usd |
CY2023Q4 | us-gaap |
Other Receivable After Allowance For Credit Loss Noncurrent
OtherReceivableAfterAllowanceForCreditLossNoncurrent
|
154622 | usd |
CY2023Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
80 | usd |
CY2022Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
80 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
5814030 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
5532062 | usd |
CY2023Q4 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
1962500 | usd |
CY2022Q4 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
1962500 | usd |
CY2023Q4 | DHCC |
Debenture Payable Current
DebenturePayableCurrent
|
50000 | usd |
CY2022Q4 | DHCC |
Debenture Payable Current
DebenturePayableCurrent
|
50000 | usd |
CY2023Q4 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
1800000 | usd |
CY2022Q4 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
1800000 | usd |
CY2023Q4 | DHCC |
Short Term Notes And Interest Bearing Advance Current
ShortTermNotesAndInterestBearingAdvanceCurrent
|
65504 | usd |
CY2022Q4 | DHCC |
Short Term Notes And Interest Bearing Advance Current
ShortTermNotesAndInterestBearingAdvanceCurrent
|
80504 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
18676733 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
17526938 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
18676733 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
17526938 | usd |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
2086000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
2086000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
|
2519080 | usd |
CY2022Q4 | us-gaap |
Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
|
2519080 | usd |
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
20860 | usd |
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
20860 | usd |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
39052472 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
39052472 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
36297576 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
36297576 | shares |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
39052 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
39052 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
36663780 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
36122078 | usd |
CY2023Q4 | us-gaap |
Unearned Esop Shares
UnearnedESOPShares
|
2490662 | usd |
CY2022Q4 | us-gaap |
Unearned Esop Shares
UnearnedESOPShares
|
2609264 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-46862802 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-45351375 | usd |
CY2023Q4 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
1084431 | shares |
CY2022Q4 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
1004886 | shares |
CY2023Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
232931 | usd |
CY2022Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
216227 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-12862703 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-11994876 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5814030 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5532062 | usd |
CY2023 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
736680 | usd |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
917756 | usd |
CY2023 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
546400 | usd |
CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
11480 | usd |
CY2023 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
67975 | usd |
CY2022 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
71450 | usd |
CY2023 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
1351055 | usd |
CY2022 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
1000686 | usd |
CY2023 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
438393 | usd |
CY2022 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
415330 | usd |
CY2023 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
377486 | usd |
CY2022 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
439689 | usd |
CY2023 | us-gaap |
Gain Loss On Condemnation
GainLossOnCondemnation
|
757107 | usd |
CY2023 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-58772 | usd |
CY2022 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-855019 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1409827 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1855705 | usd |
CY2023 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
101600 | usd |
CY2022 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
101600 | usd |
CY2023 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1511427 | usd |
CY2022 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1957305 | usd |
CY2023 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
37437576 | shares |
CY2023 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
37437576 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
36297576 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
36297576 | shares |
CY2023 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.040 | |
CY2023 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.040 | |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.054 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.054 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-10147051 | usd |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
|
98000 | usd |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
11480 | usd |
CY2022 | us-gaap |
Dividends
Dividends
|
101600 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1855705 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-11994876 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-11994876 | usd |
CY2023 | DHCC |
Adjustments To Additional Paid In Capital Common Stock To Be Issued In Connection With Notespayable Related Parties
AdjustmentsToAdditionalPaidInCapitalCommonStockToBeIssuedInConnectionWithNotespayableRelatedParties
|
70000 | usd |
CY2023 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
27200 | usd |
CY2023 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
546400 | usd |
CY2023 | us-gaap |
Dividends
Dividends
|
101600 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1409827 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-12862703 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-12862703 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1409827 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1855705 | usd |
CY2023 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
76116 | usd |
CY2022 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
141663 | usd |
CY2023 | DHCC |
Stock Based Compensation
StockBasedCompensation
|
546400 | usd |
CY2022 | DHCC |
Stock Based Compensation
StockBasedCompensation
|
11480 | usd |
CY2023 | us-gaap |
Gain Loss On Condemnation
GainLossOnCondemnation
|
757107 | usd |
CY2023 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
751405 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
775293 | usd |
CY2023 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
353986 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
786167 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-439027 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-141102 | usd |
CY2023 | us-gaap |
Proceeds From Sale Of Land Held For Use
ProceedsFromSaleOfLandHeldForUse
|
845378 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
845378 | usd |
CY2023 | us-gaap |
Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
|
40000 | usd |
CY2022 | us-gaap |
Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
|
130000 | usd |
CY2023 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
97020 | usd |
CY2023 | us-gaap |
Repayments Of Other Debt
RepaymentsOfOtherDebt
|
40000 | usd |
CY2023 | DHCC |
Repayments Of Other
RepaymentsOfOther
|
15000 | usd |
CY2023 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
118132 | usd |
CY2022 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
15104 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-36112 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
114896 | usd |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
370239 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-26206 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
55885 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
82091 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
426124 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
55885 | usd |
CY2023 | us-gaap |
Interest Paid Net
InterestPaidNet
|
56056 | usd |
CY2023 | us-gaap |
Stock Issued1
StockIssued1
|
70000 | usd |
CY2022 | us-gaap |
Stock Issued1
StockIssued1
|
98000 | usd |
CY2023 | DHCC |
Common Stock To Be Issued In Connection With Notes Payable Others
CommonStockToBeIssuedInConnectionWithNotesPayableOthers
|
27200 | usd |
CY2023 | DHCC |
Unpaid Preferred Stock Dividends In Accounts Payable And Accrued Expenses
UnpaidPreferredStockDividendsInAccountsPayableAndAccruedExpenses
|
101600 | usd |
CY2022 | DHCC |
Unpaid Preferred Stock Dividends In Accounts Payable And Accrued Expenses
UnpaidPreferredStockDividendsInAccountsPayableAndAccruedExpenses
|
101600 | usd |
CY2023 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1511427 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-46862802 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
|
13587711 | usd |
CY2023Q4 | us-gaap |
Cash
Cash
|
426124 | usd |
CY2023 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_847_eus-gaap--UseOfEstimates_zSy8obdxx4E7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zQRVcJXJvXXc">Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2023Q4 | us-gaap |
Land
Land
|
5233204 | usd |
CY2022Q4 | us-gaap |
Land
Land
|
5476097 | usd |
CY2023Q4 | us-gaap |
Litigation Settlement Expense
LitigationSettlementExpense
|
1000000 | usd |
CY2023Q4 | us-gaap |
Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
|
845378 | usd |
CY2023Q4 | us-gaap |
Litigation Settlement Expense
LitigationSettlementExpense
|
1000000 | usd |
CY2023Q4 | us-gaap |
Litigation Settlement Amount Awarded From Other Party
LitigationSettlementAmountAwardedFromOtherParty
|
154622 | usd |
CY2023 | us-gaap |
Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
|
79545 | shares |
CY2023Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
0 | usd |
CY2022Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
0 | usd |
CY2023 | DHCC |
Weighted Average Number Of Shares Yet To Issue Basic
WeightedAverageNumberOfSharesYetToIssueBasic
|
1140000 | shares |
CY2022 | DHCC |
Weighted Average Number Of Shares Yet To Issue Basic
WeightedAverageNumberOfSharesYetToIssueBasic
|
860000 | shares |
CY2023 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4815000 | shares |
CY2022 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4815000 | shares |
CY2023 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
0 | usd |
CY2022 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
0 | usd |
CY2023 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p id="xdx_845_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zRXpBh6vkUT8" style="margin: 0"><i><span id="xdx_86F_zI0Qrk8JHOT9">Reclassification</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain reclassifications have been made to the Company’s consolidated financial statements for the year ended December 31, 2023 to conform to the current period’s consolidated financial statement presentation. A reclassification of $<span id="xdx_909_ecustom--AllocatedShareBasedCompensationExpenses_c20230101__20231231_zB07bKKHQYm5" title="Share based compensation">11,480</span> from administrative and general expenses to stock-based compensation expense was recorded. The reclassification did not have any effects on the Company’s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2023 | DHCC |
Allocated Share Based Compensation Expenses
AllocatedShareBasedCompensationExpenses
|
11480 | usd |
CY2023Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
3869711 | usd |
CY2022Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
3569711 | usd |
CY2023Q4 | DHCC |
Interest Payble Related Party Current
InterestPaybleRelatedPartyCurrent
|
2897159 | usd |
CY2022Q4 | DHCC |
Interest Payble Related Party Current
InterestPaybleRelatedPartyCurrent
|
2467844 | usd |
CY2023Q4 | DHCC |
Accrued Director Fees Current
AccruedDirectorFeesCurrent
|
928750 | usd |
CY2022Q4 | DHCC |
Accrued Director Fees Current
AccruedDirectorFeesCurrent
|
838750 | usd |
CY2023Q4 | us-gaap |
Accrued Rent Current
AccruedRentCurrent
|
198983 | usd |
CY2022Q4 | us-gaap |
Accrued Rent Current
AccruedRentCurrent
|
165295 | usd |
CY2023Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
17308 | usd |
CY2022Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
17308 | usd |
CY2023Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
3115463 | usd |
CY2022Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
2841520 | usd |
CY2023Q4 | us-gaap |
Dividends Payable Current
DividendsPayableCurrent
|
1270000 | usd |
CY2022Q4 | us-gaap |
Dividends Payable Current
DividendsPayableCurrent
|
1168400 | usd |
CY2023Q4 | DHCC |
Accrued Fines And Penalties
AccruedFinesAndPenalties
|
578775 | usd |
CY2022Q4 | DHCC |
Accrued Fines And Penalties
AccruedFinesAndPenalties
|
444875 | usd |
CY2023Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
308286 | usd |
CY2022Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
463743 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
5272524 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
4918538 | usd |
CY2017Q1 | us-gaap |
Short Term Borrowings
ShortTermBorrowings
|
65504 | usd |
CY2014Q3 | us-gaap |
Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
|
0.04 | pure |
CY2023Q4 | DHCC |
Proceeds From Eminent Domain Settlement
ProceedsFromEminentDomainSettlement
|
25000 | usd |
CY2023Q4 | us-gaap |
Proceeds From Legal Settlements
ProceedsFromLegalSettlements
|
74520 | usd |
CY2023 | us-gaap |
Payments For Rent
PaymentsForRent
|
4534 | usd |
CY2023Q4 | DHCC |
Rent Expense
RentExpense
|
54408 | usd |
CY2023 | DHCC |
Associated Rental Costs
AssociatedRentalCosts
|
33689 | usd |
CY2023 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
88097 | usd |
CY2022Q4 | DHCC |
Rent Expense
RentExpense
|
54408 | usd |
CY2022 | DHCC |
Associated Rental Costs
AssociatedRentalCosts
|
30737 | usd |
CY2022 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
85145 | usd |
CY2022 | DHCC |
Allocated Share Based Compensation Expenses
AllocatedShareBasedCompensationExpenses
|
11480 | usd |
CY2023Q4 | us-gaap |
Proceeds From Legal Settlements
ProceedsFromLegalSettlements
|
74520 | usd |
CY2023Q4 | DHCC |
Remaining Balance Debt
RemainingBalanceDebt
|
480 | usd |
CY2018 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
21570 | usd |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4555000 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.41 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4555000 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.41 | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4555000 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.41 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
4555000 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0.41 | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
4555000 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0.41 | |
CY2023Q4 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
|
4555000 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
|
4555000 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
|
4555000 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
|
4555000 | shares |
CY2023Q4 | us-gaap |
Employee Stock Ownership Plan Esop Number Of Suspense Shares
EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares
|
1670465 | shares |
CY2023Q4 | us-gaap |
Employee Stock Ownership Plan Esop Deferred Shares Fair Value
EmployeeStockOwnershipPlanESOPDeferredSharesFairValue
|
350464 | usd |
CY2023 | us-gaap |
Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
|
79545 | shares |
CY2022 | us-gaap |
Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
|
79545 | shares |
CY2023 | us-gaap |
Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
|
16704 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
|
30227 | usd |
CY2023Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
5600000 | usd |
CY2023 | DHCC |
Net Operating Loss Carryforwards Expiration Date Descrption
NetOperatingLossCarryforwardsExpirationDateDescrption
|
expire during various periods through 2041 | |
CY2023 | us-gaap |
Tax Credit Carryforward Description
TaxCreditCarryforwardDescription
|
federal statutory rate of 21% to the carryforward amounts | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
1300000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
1700000 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
CY2022 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
215000 | usd |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
|
0.80 | pure |
CY2023Q4 | DHCC |
Accrued Franchise Taxes
AccruedFranchiseTaxes
|
17400 | usd |
CY2023Q4 | us-gaap |
Litigation Settlement Expense
LitigationSettlementExpense
|
1000000 | usd |
CY2023Q4 | us-gaap |
Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
|
845378 | usd |
CY2023Q4 | DHCC |
Remaining Balance Of Debt
RemainingBalanceOfDebt
|
155000 | usd |
us-gaap |
Litigation Settlement Expense
LitigationSettlementExpense
|
1500000 | usd | |
CY2023Q1 | us-gaap |
Litigation Settlement Expense
LitigationSettlementExpense
|
1500000 | usd |